Chronic fatigue with a gender- perspective in the Swedish Twin Registry; definitions and heterogeneity.

Slides:

Advertisements

Similar presentations

Bipolar and Related Disorders. Bipolar & Related Disorders – Bipolar I disorder – Bipolar II disorder – Cyclothymic disorder – Substance induced bipolar.

Advertisements

Epidemiological study of mild cognitive impairment and pilot evaluation of methods of early dementia detection in Chinese community Yueqin Huang MD MPH.

Chronic fatigue syndrome. Meet Martha Martha, 32, is a Manager with a BPO. She has a busy routine. She has been coping with a busy lifestyle for over.

PRACTICE PARAMETER: RISK OF DRIVING AND ALZHEIMER ’ S DISEASE (AN EVIDENCE-BASED REVIEW) Richard M. Dubinsky, MD; Anthony C. Stein, PhD; and Kelly Lyons,

Case-Control Studies (Retrospective Studies). What is a cohort?

《 Promotion of Capability and Effectiveness for Tobacco Control Program among Rural Residents* 》 --Report On The Baseline Survey (Tobacco use status among.

The DASH Study Patrick Leonberger MSIV BGSMC Nov 8, 2013.

Hepatitis B: Epidemiology

Role of Antiretroviral Therapy, Viral Replication, and HIV Infection in Atherosclerosis Priscilla Y. Hsue, Peter W. Hunt, Jeffrey N. Martin, Amanda Schnell,

EVIDENCE BASED MEDICINE

CHRONIC FATIGUE SYNDROME (CFS) DIAGNOSTIC AND ASSESSMENT ISSUES.

Physical Examination of Chronic Fatigue Syndrome Bali Mental Hospital Shin-Min Lee May, 2005.

® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,

Sexual Risk Behaviors and Sexually Transmitted Infection (STI) Prevalence in an Outpatient Psychiatry Clinic LH Bachmann 1,2, J Feldman 1, Y Waithaka 1.

ScandinaviaOdense, home town of Hans Christian Andersen.

Comorbidity in SLE Compared with Rheumatoid Arthritis and Non-inflammatory Disorders Frederick Wolfe 1, Kaleb Michaud 1,2, Tracy Li 3, Robert S. Katz 4.

Multiple Choice Questions for discussion

Health Status of Australian Adults. The health status of Australians is recognised as good and is continually improving. The life expectancy for males.

Evidence-Based Medicine 4 More Knowledge and Skills for Critical Reading Karen E. Schetzina, MD, MPH.

Introduction Chronic obstructive pulmonary disease (COPD) is related to increased fatigue, decreased health status, and increased mortality. Studies with.

Quality of Life and Depression as Determinants of Treatment Adherence in Hypertensive Leonelo E. Bautista 1 ; Paul Smith 2 ; Cynthia Colombo 2 ; Dennis.

Mood Disorders: Bipolar

Chronic Fatigue Syndrome (CFS) Jonathan Cooke Kevin Repay Tara Ruberto

Jaw Pain: Characteristics and Prevalence in Fibromyalgia and other Rheumatic Disorders Robert S. Katz 1, Frederick Wolfe 2. 1 Rush University Med Center,

Parental Alcohol Problems and Early Sexual Debut in Young Adult Women Claudia Gambrah, Alexis E. Duncan, Andrew C. Heath.

Evidence-Based Medicine 3 More Knowledge and Skills for Critical Reading Karen E. Schetzina, MD, MPH.

Introduction ► College-student drinking remains a significant problem on campuses across the nation. ► It is estimated that 38-44% of college students.

MARC Project 4: Australian Children of Alcoholic Female Twins.

Fibromyalgia Patients Reading Self-Help Journals and in Internet Self-Help Groups: Are They Different from Patients in Clinical Practice? Robert Katz 1,

Leapfrog’s “Survival Predictor”: Composite Measures for Predicting Hospital Surgical Mortality May 7, 2008.

Goldstein (1988) Gottesman & Shields (1966)

Do We Need to Screen our IBD Patients for Depression: The Prevalence and Severity of Depression within a Typical DGH Cohort of IBD Patients N. Swart 1,

Jeffrey F. Scherrer (1,2); Hong Xian (2); Andrew C. Heath (1,2); Theodore Jacob (1); William R. True (1,3), Kathleen K. Bucholz (1,2) Smoking in Offspring.

What is Development? Systematic changes and continuities –In the individual –Between conception and death “Womb to Tomb” Three broad domains –Physical,

Raj Patel, M.D. Chronic Fatigue Key To Successful Treatment Raj Patel, MD Medical Options for Wellness Los Altos, CA

Various topics Petter Mostad Overview Epidemiology Study types / data types Econometrics Time series data More about sampling –Estimation.

MARC Project 4: Australian Children of Alcoholic Female Twins Wendy S. Slutske, Valerie S. Knopik, Theodore Jacob, Michael T. Lynskey, & Anne Glowinski.

Copyright restrictions may apply Predictive Values of Psychiatric Symptoms for Internet Addiction in Adolescents: A 2-Year Prospective Study Ko C-H, Yen.

HARMONY Study of Dementia in Swedish Twins health Hälsa genes ARv environment Miljö and Och newNY NIA grant R01AG08724 and the Alzheimer’s Association.

Associations Among Parental Alcohol Problems, Trauma, and Depression in a Twin Sample Vivia V. McCutcheon, MSW; Andrew C. Heath, D.Phil.; Elliot C. Nelson,

Psychological Distress and Recurrent Pain: Results from the 2002 NHIS Psychological Distress and Recurrent Pain: Results from the 2002 NHIS Loren Toussaint,

Introduction Psychological factors have been implicated to be etiologies for idiopathic environmental illness (IEI) in many studies. No study has ever.

BISEXUAL CONCURRENCY,BISEXUAL PARTNESHIPS,AND HIV AMONG SOUTHERN AFRICA MEN WHO HAVE SEX WITH MEN (MSM) Presenter: Gift Trapence Organisation: Centre for.

Findings from Taylor & Jason (2001) study Taylor, R.R. & Jason, L.A. (2001). Sexual abuse, physical abuse, chronic fatigue, and chronic fatigue syndrome:

1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.

Prevalence of Dry Eye Disease among Elderly Korean Population Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Won Ryang Wee, MD, 2,3 Jin Hak Lee, MD, 1, 3.

Genetic and Environmental Influences on Perceived Peer Alcohol Use During Adolescence Julia D. Grant 1, Kathleen K. Bucholz 1, Pamela A.F. Madden 1, Wendy.

New development in ME – Myalgic Encephalomyelitis in Norway Marianne Bjærum Christine Normann.

Heart Disease Example Male residents age Two models examined A) independence 1)logit(╥) = α B) linear logit 1)logit(╥) = α + βx¡

Do genetic influences on abuse and dependence overlap? Explorations using cannabis and alcohol diagnoses. Julia D. Grant and Kathleen K. Bucholz Washington.

Clinical Epidemiology and Evidence-based Medicine Unit FKUI – RSCM

Surveillance and Population-based Prevention Department for Prevention of Noncommunicable Diseases Displaying data and interpreting results.

Case Control Studies Dr Amna Rehana Siddiqui Department of Family and Community Medicine October 17, 2010.

Analytical Studies Case – Control Studies By Dr. Sameh Zaytoun (MBBch, DPH, DM, FRCP(Manch), DTM&H(UK),Dr.PH) University of Alexandria - Egypt Consultant.

ALDH2 and Conduct Disorder Mediate Ethnicity and Alcohol Dependence in Chinese-, Korean-, and White-American College Students S.E. Luczak, T.A.R. Cook,

CoRPS Center of Research on Psychology in Somatic diseases Multiple myeloma survivors experience a low quality of life and many disease-specific complaints:

Smoking in England Robert West Jamie Brown University College London 1.

Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.

CHRONIC FATIGUE SYNDROME Danielle Lafferty, EXS 486.

Predictors of Functioning in Women with Fibromyalgia Syndrome (FMS) Alexa Stuifbergen, PhD, RN, FAAN Professor Dolores V.Sands Chair in Nursing Research.

Meta-analysis of observational studies Nicole Vogelzangs Department of Psychiatry & EMGO + institute.

Some epidemiological principles and methods

Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder,

. Troponin limit of detection plus cardiac risk stratification scores for the exclusion of myocardial infarction and 30-day adverse cardiac events in ED.

Fatigue in road, rail and maritime transport

Suzanne M. Dolwick Grieb, MSPH: University of Florida (UF)

The objective of this lecture is to know the role of random error (chance) in factor-outcome relation and the types of systematic errors (Bias)

2 Division of Geriatrics, McGill University Center, Montreal

Public Health Implications

Presentation transcript:

Chronic fatigue with a gender- perspective in the Swedish Twin Registry; definitions and heterogeneity

Epidemiology of CF Prolonged fatigue, chronic fatigue, chronic fatigue-like illness, chronic fatigue syndrome

CFS persons in the US Cost estimated to 9 billion dollars annually for loss of production alone

Why study chronic fatigue? More appropriate to ask why have we not studied it earlier? Sweden pay 12 billion Euro every year for people on sick-leave 62% of the working population are in the working-force, A majority of the rest are on sick-leave or in early retirement due to illness; fatigue is a major symptom in many of these illnesses and diseases.

STR STR= Swedish Twin Registry = the Swedish population A populationbased epidemiological study Funded by NIH and others

Two large population-based studies Chicago Illinois (Jason 1999, DePaul U.) telephone interviews ages 18 - >60 7,7% prolonged fatigue 4,2% chronic fatigue CFS-like group n= 408 Invitation to clinical evaluation n= 166 (41%) Estimated prevalence: 0,42% (CI 0,29 – 0,56) Gender-specific prevalence –Women: 0,522% –Men: 0,291%

Two large population-based studies Wichita Kansas (Reyes 2003, CDC) 7162 telephone interviews ages 18 – 69 9,4% prolonged fatigue CFS-like group n=555 Invitation to clinical evaluation n=299 (54%) Estimated prevalence: 0,235% (CI 0,14 – 0,32) Gender-specific prevalence: –Women 0,373% –Men 0,083%

One nation-wide study Iceland (Lindal 2002) Only telephone interview n= 2471 Using criteria by Fukuda 1994 Estimated prevalence: 1,4% Gender-specific prevalence: –Women:1,0% –Men:0,3%

The Swedish Twin Registry twins DZ / MZ ~ 1,5

The STR - CFS study SALT Screening Across the Lifespan Twin study 1998 – 2002: telephone interview Ages 42 – 64 years (born 1935 – 1958) Questions regarding Chronic Fatigue: –”Have you felt abnormally tired during the last six months?” –Duration, impairment (too tired to live a normal life), work incapacity –Occurence of 8 symptoms defining CFS

The STR – CFS study 41,499 individual twins eligible for interview 31,406 individuals responded (75,7%) 12,407 complete twin pairs

The STR – CFS study All responsive to fatigue question: –6,571 = 20,92% Prolonged fatigue (> 1 month): –3,826 = 12,33% CF-A (> 6 months): –2,564 = 8,26% CF-B (6 months + impairment): –1,823 = 5,87% CF-C (6 months, imp. + 4/8 symptoms): –732 = 2,36%

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Fatigue (N=6,571, 20.92%) Prolonged Fatigue (N=3,826, 12.33%) CF-A (add ¡Ã6 months) (N=2,564, 8.26%) CF-B (add impairment) (N=1,823, 5.87%) CF-C (add  4 symptoms) (N=732, 2.36%) Details Figure 1 Fatigue (remove exclusions) (N=5,330, 17.17%)

Epidemiological conclusions The six-month prevalence of CFS-like illness was 2.36% Markedly higher in women No association with age No association with education No assocation with occupation-analysis of the gender-divided workingmarket

Cases of prolonged fatigue -history, physical exam -Mental status -Routine tests (biochemical, microbiological Exclusion CFS case: -Severe fatigue: new/definitive onset -6 months -Not alleviated by rest -Reduction in activities -4/8 symptoms: -Impaired memory/concentration -Sore throat -Tender lymph nodes -Muscle pain -Multi-joint pain -New headaches -Unrefreshing sleep -Post-exertional malaise Idiopathic chronic fatigue: If fatigue severity or symptom criteria not met.

Symptoms in Fatigued subjects 5,330 fatigued twins, women 64,17% Mean number of symptoms: 2,4 Median: 2,0 Most common symptoms: –Unrefreshing sleep (79,9%) –Memory impairment (48,5%) –Muscle pain (37,3%) –Joint pain (28,3%)

Symptoms in Fatigued subjects 5,330 fatigued twins, women 64,17% Mean number of symptoms: 2,4 Median: 2,0 Least common symptoms: –Tender lymph nodes (6,9%) –Headaches (11,1%) –Sore throat (12,0%) –Post-exertional malaise (15,8%)

Figure 1: Trellis graph depicting the relationships with the 0, 1, 2, …, 8 cardinal CFS symptoms. Panel A shows the proportion of subjects. Panel B depicts the mean duration of fatigue in months. Panel C shows the proportion of females. Panels E through L depict the proportions of subjects with each of the individual symptoms. By definition, Panels E-L are fixed at 0% for zero total symptoms and 100% for eight total symptoms. A vertical reference line is shown at the CDC cut point between 3 and 4 total symptoms.

Symptoms counted Almost linear progression in number of symptoms with duration of disease No clear cut-point between 3 and 4 symptoms Using logistic regression, which symptoms will help define the most stringent definition of fatigue?

1 0 ∞ OR < 1 protective OR = 1 No risk OR > 1 Riskfactor Risk: 0 – 1. If disease rare, OR = RR

Logistic regression Memory deterioration: –OR 1,76 in prolonged fatigue, OR 11,3 in CF-C Muscle pain: –OR 1,38 in PF, OR 8,92 in CF-C Joint pain: –OR 1,64 in PF, OR 7,54 in CF-C Lymph nodes, headache: –OR starting < 1,0 Sore throat: –OR 0,70 in PF, OR 0,71 in CF-B, OR 1,47 in CF-C

Logistic regression The 8 symptoms not equivalent in predicting fatigue classification Prevalence figures from interview –Tender lymph nodes 7% –Unrefreshing sleep 80% Maybe symptoms should be dropped and focus put on duration, impairment ?

Latent class analysis Mathematical modelling Finds hidden patterns Within each latent class, each variable is independent of every other variable If latent class effect is removed, only effect of randomness remains

Latent class analysis in CFS 11 dichotomous items entered: –Gender –Impairment –Duration +/- 6 months –All the 8 symptoms Theoretical number of patterns: 2048 Observed number: 679 With 5 classes, all cases will fit

Latent classes Class 1: 87% women, high endorsement of the 8 symptoms, depression, CWP. Most in this class fitted into CF-C (86%) –CFS-like class

Latent classes Class 1: 87% women, high endorsement of the 8 symptoms, depression, CWP. Most in this class fitted into CF-C (86%) –CFS-like class Class 2: 44% women, few symptoms –Residual class

Latent classes Class 1: 87% women, high endorsement of the 8 symptoms, depression, CWP. Most in this class fitted into CF-C (86%) –CFS-like class Class 2: 44% women, few symptoms –Residual class Class 3: 65% women, muscle & joint pain, low occurence of true CF-C (11%) –Rheumatic class

Class 4: 65% women, memory deterioration, 44% depressed –Depressive class

Class 5: 61% women, shorter duration, sore throat –Acute Physical syndrome Class 4: 65% women, memory deterioration, 44% depressed –Depressive class

Class 1: 87% women, high endorsement of the 8 symptoms, depression, CWP. Most in this class fitted into CF-C (86%) –CFS-like class Class 2: 44% women, few symptoms –Residual class Class 3: 65% women, muscle & joint pain, low occurence of true CF-C (11%) –Rheumatic class Class 4: 65% women, memory deterioration, 44% depressed –Depressive class Class 5: 61% women, shorter duration, sore throat –Acute Physical syndrome

Latent classes The traits presented in the differented classes illustrate the heterogeneity of chronic fatigue Class 1 CFS –like? Class 3 & 4 common complaints in this age group Class 5 viral infections?  implications for how surveys are conducted (acute physical syndrome will tend to resolve)

Ongoing studies Twin statistics for genetic and environmental influence Molecular epidemiology; genomics and proteomics in monozygotic twins Early life events PET-studies

Issues Sex and Gender Biological differences Genetic differences Environmental differences Physical, Social, Psychological Integrative approach needed!

This illness is costly for society Should have an adequate part of R&D

Fatigue in the Swedish Twin Registry Nancy Pedersen, prof, head of STR at KI Birgitta Evengård, assoc prof, MD, KI Andreas Jacks, MD, KI Kenji Kato, KI Patrick Sullivan, prof, MD, Univ North Carolina

Heritability All possible combinations of symptoms 1x1... 8x8, total 255 Assessed for female-female and male-male pairs Possible feature of interest: –Multi-joint pain in females and males –Sore-throat – lymph nodes headaches in males

Female-female twin pairs Figure 2: Depicted are the estimated heritabilities for all possible combinations of items. Panel A shows data for female-female twin pairs and Panel B shows male-male twin pairs. Horizontal reference lines show the overall 75 th, 50 th, and 25 th percentiles for each gender.

Male-male twin pairs Figure 2: Depicted are the estimated heritabilities for all possible combinations of items. Panel A shows data for female-female twin pairs and Panel B shows male-male twin pairs. Horizontal reference lines show the overall 75 th, 50 th, and 25 th percentiles for each gender.

Female-female twin pairs Male-male twin pairs

Individual twins eligible for CFS screening interview (N=41,499) Figure 1

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Figure 1

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Figure 1

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Fatigue (N=6,571, 20.92%) Figure 1

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Fatigue (N=6,571, 20.92%) Details Figure 1 Fatigue (remove exclusions) (N=5,330, 17.17%)

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Fatigue (N=6,571, 20.92%) Prolonged Fatigue (N=3,826, 12.33%) Details Figure 1 Fatigue (remove exclusions) (N=5,330, 17.17%)

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Fatigue (N=6,571, 20.92%) Prolonged Fatigue (N=3,826, 12.33%) Details Figure 1 Fatigue (remove exclusions) (N=5,330, 17.17%)

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Fatigue (N=6,571, 20.92%) Prolonged Fatigue (N=3,826, 12.33%) CF-A (add ¡Ã6 months) (N=2,564, 8.26%) Details Figure 1 Fatigue (remove exclusions) (N=5,330, 17.17%)

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Fatigue (N=6,571, 20.92%) Prolonged Fatigue (N=3,826, 12.33%) CF-A (add ¡Ã6 months) (N=2,564, 8.26%) Details Figure 1 Fatigue (remove exclusions) (N=5,330, 17.17%)

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Fatigue (N=6,571, 20.92%) Prolonged Fatigue (N=3,826, 12.33%) CF-A (add ¡Ã6 months) (N=2,564, 8.26%) CF-B (add impairment) (N=1,823, 5.87%) Details Figure 1 Fatigue (remove exclusions) (N=5,330, 17.17%)

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Fatigue (N=6,571, 20.92%) Prolonged Fatigue (N=3,826, 12.33%) CF-A (add ¡Ã6 months) (N=2,564, 8.26%) CF-B (add impairment) (N=1,823, 5.87%) Details Figure 1 Fatigue (remove exclusions) (N=5,330, 17.17%)

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Fatigue (N=6,571, 20.92%) Prolonged Fatigue (N=3,826, 12.33%) CF-A (add ¡Ã6 months) (N=2,564, 8.26%) CF-B (add impairment) (N=1,823, 5.87%) CF-C (add  4 symptoms) (N=732, 2.36%) Details Figure 1 Fatigue (remove exclusions) (N=5,330, 17.17%)

Individual twins eligible for CFS screening interview (N=41,499) Participants, fatigue evaluated by interview (N=31,406, 75.68%) Non-responders (N=10,093, 24.32%) Predictors of participation: - Monozygous twin (OR=1.68, p<.0001) - Eligible co-twin (OR=1.44, p<.0001) - Female gender (OR=1.39, p<.0001) - Fewer hospitalizations (OR=1.18, p<.0001) - Age (OR=1.007, p=0.0001, but R 2 =0.0002) - In cancer registry (OR=1.01, NS) Denied stem question (N=24,467, 77.91%) Missing data (N=368, 1.17%) Fatigue (N=6,571, 20.92%) Prolonged Fatigue (N=3,826, 12.33%) CF-A (add ¡Ã6 months) (N=2,564, 8.26%) CF-B (add impairment) (N=1,823, 5.87%) CF-C (add  4 symptoms) (N=732, 2.36%) Details Figure 1 Fatigue (remove exclusions) (N=5,330, 17.17%)

Clinical study phase 732 twins with Chronic Fatigue CF-C MZ twins discordant for fatigue: –N = 235 Invitation letter Telephone interview Clinical visit for correct diagnosis, detecting exclusionary diagnosis –N = 110 Biological sampling – routine Biological sampling - research

Latent classes Class 1: 87% women, high endorsement of the 8 symptoms, depression, CWP. Most in this class fitted into CF-C (86%)

Latent classes Class 1: 87% women, high endorsement of the 8 symptoms, depression, CWP. Most in this class fitted into CF-C (86%) –CFS-like class Class 2: 44% women, few symptoms

Latent classes Class 1: 87% women, high endorsement of the 8 symptoms, depression, CWP. Most in this class fitted into CF-C (86%) –CFS-like class Class 2: 44% women, few symptoms –Residual class Class 3: 65% women, muscle & joint pain, low occurence of true CF-C (11%)

Latent classes Class 1: 87% women, high endorsement of the 8 symptoms, depression, CWP. Most in this class fitted into CF-C (86%) –CFS-like class Class 2: 44% women, few symptoms –Residual class Class 3: 65% women, muscle & joint pain, low occurence of true CF-C (11%) –Rheumatic class Class 4: 65% women, memory deterioration, 44% depressed

Latent classes Class 1: 87% women, high endorsement of the 8 symptoms, depression, CWP. Most in this class fitted into CF-C (86%) –CFS-like class Class 2: 44% women, few symptoms –Residual class Class 3: 65% women, muscle & joint pain, low occurence of true CF-C (11%) –Rheumatic class Class 4: 65% women, memory deterioration, 44% depressed –Depressive class

Latent classes Class 1: 87% women, high endorsement of the 8 symptoms, depression, CWP. Most in this class fitted into CF-C (86%) –CFS-like class Class 2: 44% women, few symptoms –Residual class Class 3: 65% women, muscle & joint pain, low occurence of true CF-C (11%) –Rheumatic class Class 4: 65% women, memory deterioration, 44% depressed –Depressive class

Latent classes Class 1: 87% women, high endorsement of the 8 symptoms, depression, CWP. Most in this class fitted into CF-C (86%) –CFS-like class Class 2: 44% women, few symptoms –Residual class Class 3: 65% women, muscle & joint pain, low occurence of true CF-C (11%) –Rheumatic class Class 4: 65% women, memory deterioration, 44% depressed –Depressive class Class 5: 61% women, shorter duration, sore throat

Different study types Population-based surveys –Questionnaires2-3 % –Telephone interview0,007 – 0,23% –+/- clinical ascertainment Specialist centres (referred patients) –0,04 – 2,6% Unique cohorts –twin registries –Occupational medicine etc

Figure 2: Six month prevalence of fatigue-related definitions of increasing severity. The y-axis shows the current prevalence of each definition, and the x-axis contains five definitions of fatigue-related illness of increasing stringency and similarity to CFS. Shown are the prevalences overall and by gender as proportions of the sample. Filled circles show the estimates and the vertical bars depict asymptotic 95% confidence intervals. A line connects the overall prevalence estimates; all estimates for males are below and estimates for females above this line.

Figure 1: Trellis graph depicting the relationships with the 0, 1, 2, …, 8 cardinal CFS symptoms. Panel A shows the proportion of subjects. Panel B depicts the mean duration of fatigue in months. Panel C shows the proportion of females. Panels E through L depict the proportions of subjects with each of the individual symptoms. By definition, Panels E-L are fixed at 0% for zero total symptoms and 100% for eight total symptoms. A vertical reference line is shown at the CDC cut point between 3 and 4 total symptoms.